The DOI matches its Crossref record.
Antifibrogenic Effect of A Deletion Variant of Hepatocyte Growth Factor on Liver Fibrosis in Rats
Open accessAbstract
Hepatic fibrosis, which may lead to cirrhosis, is associated with most chronic liver diseases. Current therapies for hepatic fibrosis are, however, generally ineffective. In this report we assessed the efficacy of the treatment of hepatic fibrosis with a naturally occurring deletion variant of hepatocyte growth factor (dHGF). The administration of dHGF increased liver weight and suppressed the increase of hepatic collagen content in rats treated with dimethylnitrosamine (DMN) to induce hepatic fibrosis. Furthermore, dHGF exerted its mitogenic and antifibrogenic activities even after the liver fibrosis had been established with DMN. Northern blot analysis showed that dHGF suppressed the increase of messenger RNA (mRNA) levels of procollagen α2(I), αl(III), α1(IV), transforming growth factor β1 (TGF–β1), desmin (a marker of hepatic lipocytes), and α–smooth muscle (sm)–actin (a marker of activated hepatic lipocytes). In addition to suppressing the elevated TGF–β1, mRNA level in hepatic fibrosis, dHGF had a potent ability to decrease TGF–β1 mRNA level even in a normal liver. Immunohistochemical analysis revealed that desmin–positive cells and α–sm–actin–positive cells were increased in the hepatic fibrosis, whereas neither cells were seen in livers of DMN–treated rats given dHGF. We conclude that dHGF prevents and improves the DMN–induced hepatic fibrosis in rats by reducing mRNA levels of procollagens and TGF–β1, by inhibiting an activation of hepatic lipocytes, and by stimulating liver regeneration. dHGF may be useful for and applicable to the treatment of fibrosis in chronic liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Self-citationYasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
Self-citationRoles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in Bioscience · doi:10.2741/a812 · Cited by 783
RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., Morinaga, T., & Higashio, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9788 · Cited by 746
Self-citationEmerging insights into Transforming growth factor Smad signal in hepatic fibrogenesis
Inagaki, Y., & Okazaki, I. (2007) · Gut · doi:10.1136/gut.2005.088690 · Cited by 464
Roles of TGF-beta in hepatic fibrosis
Gressner, A. (2002) · Frontiers in Bioscience · doi:10.2741/gressner · Cited by 405
Hepatocyte Growth Factor (HGF) as a Tissue Organizer for Organogenesis and Regeneration
Matsumoto, K., & Nakamura, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7517 · Cited by 358
Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases
Matsumoto, K., & Nakamura, T. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00717.x · Cited by 353
Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
Li, D., & Friedman, S. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01928.x · Cited by 343
Mizuno, S., Kurosawa, T., Matsumoto, K., Mizuno-Horikawa, Y., Okamoto, M., & Nakamura, T. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1709 · Cited by 254
Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis
Zhao, W. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i10.1048 · Cited by 140
Taı̈eb, J., Delarche, C., Paradis, V., Mathurin, P., Grenier, A., Crestani, B., Dehoux, M., Thabut, D., Gougerot-Pocidalo, M.-A., Poynard, T., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00276-8 · Cited by 73
Nakagawa, N., Yasuda, H., Yano, K., Mochizuki, S.-I., Kobayashi, N., Fujimoto, H., Shima, N., Morinaga, T., Chikazu, D., Kawaguchi, H., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1601 · Cited by 64
Self-citationBone Marrow Stromal Cells Control the Growth of Hepatic Stellate Cells in vitro
Shi, L., Li, G., Wang, J., Sun, B., Yang, L., Wang, G., Wang, D., Mu, L., Chen, H., Jin, L., et al. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0227-9 · Cited by 7
Metadata
- Authors
- Yasuda, H., Imai, E., Shiota, A., Fujise, N., Morinaga, T., & Higashio, K.
- Venue
- Hepatology
- Published
- 1996-09
- Volume
- 24
- Issue
- 3
- Pages
- 636-642
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2037269059
- Cited by
- 162
- References
- 0
- FWCI
- 7.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.